BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
Go back to BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update| Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) | Delayed: 1.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.17 | 52 Week High | $3.87 | |||
| Open | $1.17 | 52 Week Low | $1.90 | |||
| Day High | $1.17 | P/E | N/A | |||
| Day Low | $1.17 | EPS | $-0.03 | |||
| Volume | 11,304 | |||||
